Alpha-fetoprotein regulatory transcription factors (AFP-TFs)

Alpha-fetoprotein (AFP) regulatory transcription factors are a collective group of proteins that control the spatial and temporal expression of the AFP gene, primarily in the liver and yolk sac. This group includes activators such as Hepatocyte Nuclear Factor 1 (HNF-1) and FOXA (HNF-3), which bind to the AFP promoter and its three distinct enhancers to drive high expression during fetal development [Spear, 1999, PMID: 10202131]. Conversely, the zinc-finger protein ZBTB20 acts as a potent transcriptional repressor that binds the AFP promoter to silence its expression shortly after birth [Xie et al., 2008, PMID: 18519620]. In the context of disease, the reactivation of these factors or the loss of repressive control is a hallmark of hepatocellular carcinoma (HCC) and certain germ cell tumors, where AFP serves as a critical diagnostic biomarker [Long et al., 2018, PMID: 30109214]. While these transcription factors are vital for liver homeostasis and development, they are historically considered "undruggable" due to their lack of small-molecule binding pockets and their broad regulatory roles across the genome. Current therapeutic strategies focus on modulating the upstream signaling pathways that influence these factors or using epigenetic modifiers to restore normal gene silencing in malignant cells. These factors are also studied in the context of liver regeneration, where transient AFP expression is often observed.

Other names

AFP promoter-binding factorsHepatic AFP-regulatory factorsAFP-regulatory transcription factor complexZBTB20HNF1AFOXA1FOXA2GATA4

Regulation of Alpha-fetoprotein (AFP) gene transcription through sequence-specific binding to the AFP promoter and enhancer elements (EI, EII, and EIII).